This topic contains a solution. Click here to go to the answer

Author Question: A 3.0-kg bowling ball experiences a net force of 8.0 N. What will be its acceleration? a. 24 m/s2 ... (Read 141 times)

nenivikky

  • Hero Member
  • *****
  • Posts: 516
A 3.0-kg bowling ball experiences a net force of 8.0 N. What will be its acceleration?
 a. 24 m/s2
  b. 3.0 m/s2
  c. 8.0 m/s2
  d. 2.7 m/s2
  e. 0.38 m/s2

Question 2

What condition must apply to a system's state of motion for it to be regarded as an inertial frame of reference?
 a. in decreasing velocity
  b. in constant velocity
  c. in constant acceleration
  d. in increasing acceleration



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

ms_sulzle

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

d

Answer to Question 2

b



nenivikky

  • Hero Member
  • *****
  • Posts: 516
Both answers were spot on, thank you once again




 

Did you know?

The Centers for Disease Control and Prevention (CDC) was originally known as the Communicable Disease Center, which was formed to fight malaria. It was originally headquartered in Atlanta, Georgia, since the Southern states faced the worst threat from malaria.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

All adverse reactions are commonly charted in red ink in the patient's record and usually are noted on the front of the chart. Failure to follow correct documentation procedures may result in malpractice lawsuits.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library